Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Raw Materials (2020 - 2026)

Bioventus filings provide 6 years of Raw Materials readings, the most recent being $21.2 million for Q4 2025.

  • On a quarterly basis, Raw Materials fell 3.88% to $21.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $21.2 million, a 3.88% decrease, with the full-year FY2025 number at $21.2 million, down 3.88% from a year prior.
  • Raw Materials hit $21.2 million in Q4 2025 for Bioventus, down from $21.9 million in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $26.4 million in Q3 2023 to a low of $3.4 million in Q4 2021.
  • Median Raw Materials over the past 5 years was $21.6 million (2025), compared with a mean of $18.8 million.
  • Biggest five-year swings in Raw Materials: surged 414.05% in 2022 and later decreased 11.23% in 2024.
  • Bioventus' Raw Materials stood at $12.2 million in 2021, then skyrocketed by 51.1% to $18.5 million in 2022, then rose by 14.13% to $21.1 million in 2023, then increased by 4.92% to $22.1 million in 2024, then decreased by 3.88% to $21.2 million in 2025.
  • The last three reported values for Raw Materials were $21.2 million (Q4 2025), $21.9 million (Q3 2025), and $23.4 million (Q2 2025) per Business Quant data.